| Target Price | $117.30 |
| Price | $84.14 |
| Potential |
39.41%
register free of charge
|
| Number of Estimates | 15 |
|
15 Analysts have issued a price target Agilon Health Inc 2027 .
The average Agilon Health Inc target price is $117.30.
This is
39.41%
register free of charge
$153.30
82.20%
register free of charge
$6.31
92.50%
register free of charge
|
|
| A rating was issued by 20 analysts: 7 Analysts recommend Agilon Health Inc to buy, 12 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Agilon Health Inc stock has an average upside potential 2027 of
39.41%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 5.93 | 5.88 |
| 2.11% | 0.89% | |
| EBITDA Margin | -6.72% | 1.46% |
| 54.18% | 121.73% | |
| Net Margin | -6.60% | -0.59% |
| 53.68% | 91.06% |
17 Analysts have issued a sales forecast Agilon Health Inc 2026 . The average Agilon Health Inc sales estimate is
This results in the following potential growth metrics:
17 Analysts have issued an Agilon Health Inc EBITDA forecast 2026. The average Agilon Health Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
17 Agilon Health Inc Analysts have issued a net profit forecast 2026. The average Agilon Health Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -23.63 | -2.06 |
| 49.37% | 91.28% | |
| P/E | negative | |
| EV/Sales | 0.21 |
17 Analysts have issued a Agilon Health Inc forecast for earnings per share. The average Agilon Health Inc EPS is
This results in the following potential growth metrics and future valuations:
Agilon Health Inc...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Bernstein |
Locked
➜
Locked
|
Locked | Sep 15 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Aug 24 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| Benchmark |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Bernstein:
Locked
➜
Locked
|
Sep 15 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 24 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Aug 06 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


